(RTTNews) - The Singapore stock market has alternated between positive and negative finishes through the last six trading days since the end of ending the two-day slide in which it had slipped more than a dozen points or 0.25 percent. The Straits Times Index now rests just beneat
(RTTNews) - The Singapore stock market has alternated between positive and negative finishes through the last six trading days since the end of ending the two-day slide in which it had slipped more than a dozen points or 0.25 percent. The Straits Times Index now rests just beneat
Japan is forging ahead with an investment plan that could see as much as 1 trillion yen (US$6.3 billion) pumped into its shipbuilding sector as it tries to wrest back greater control of a key strategic industry. However, analysts said money alone would not be enough to restore Japan’s former standing in a sector now dominated by China, with higher costs, labour shortages and years of lost capacity...
Japan is forging ahead with an investment plan that could see as much as 1 trillion yen (US$6.3 billion) pumped into its shipbuilding sector as it tries to wrest back greater control of a key strategic industry. However, analysts said money alone would not be enough to restore Japan’s former standing in a sector now dominated by China, with higher costs, labour shortages and years of lost capacity all standing in the way. The effort has taken on greater urgency as turmoil in the Middle East has...
Alibaba Group Holding Ltd. ’s cloud division led a 2 billion yuan ($293 million) funding round for ShengShu Technology , bolstering the war chest of a young contender in China’s crowded AI video contest. The Beijing-based startup also drew backing from Baidu Ventures and Luminous Ventures, it said in a statement without disclosing its valuation. The capital injection comes just two months after th...
Alibaba Group Holding Ltd. ’s cloud division led a 2 billion yuan ($293 million) funding round for ShengShu Technology , bolstering the war chest of a young contender in China’s crowded AI video contest. The Beijing-based startup also drew backing from Baidu Ventures and Luminous Ventures, it said in a statement without disclosing its valuation. The capital injection comes just two months after the maker of the Vidu video generator raised 600 million yuan. Vidu is in a capital-intensive race to develop video generation tools that’s pulled in tech heavyweights like ByteDance Ltd. , Alibaba and Kuaishou Technology , as well as upstarts like PixVerse , which is also backed by Alibaba. They aim to fill the gap left after OpenAI shuttered its Sora project to focus on core GPT models. Earlier in the week, the release of a new video generator dubbed Happy Horse — whose developer has not yet been revealed — triggered an investment flurry in Chinese AI stocks after speculation that its author was a local company. The new AI tool outperformed ByteDance’s Seedance 2 as the best text-to-video service on the Artificial Analysis chart . Vidu ranks ninth on that list. Read More: Chinese Media Stocks Gain as New AI Video Model Sparks Optimism Alibaba, for its part, is one of the most active backers of Chinese artificial intelligence startups, hoping the financing will drive usage of its cloud computing platform, which has overtaken e-commerce as its fastest-growing moneymaker. Founded in March 2023, ShengShu was started by Tsinghua University professor Zhu Jun, who serves as its chief scientist. Its early backers include Qiming Venture Partners , Baidu Inc. and a Beijing government fund. In 2025, the company reported more than tenfold growth in both users and revenue, without disclosing specific figures. Vidu has reached users in over 200 countries and regions worldwide, spanning industries such as animation, advertising and film. In December, ShengShu open-sourced Motus — a new AI...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, presented for the first time the preclinical data of IBI3055, a proprietary anti-CD19/BCMA/CD3 tri-specific T cell eng...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, presented for the first time the preclinical data of IBI3055, a proprietary anti-CD19/BCMA/CD3 tri-specific T cell engager for the treatment of autoimmune diseases, as an oral presentation at the 2026 Immune Resetting:
格隆汇4月10日|美国邮政总局(U.S. Postal Service)表示,为应对财务危机,计划从7月12日起将“永久邮票”(First-Class Mail Forever stamp)的价格上调约5%,从78美分涨至82美分。该机构还计划将国内明信片的邮寄价格上调6.6%,从61美分涨至65美分。国际明信片的邮寄费用将上涨2.9%,从1.70美元涨至1.75美元。此次拟议的提价须经邮政管理委...
格隆汇4月10日|美国邮政总局(U.S. Postal Service)表示,为应对财务危机,计划从7月12日起将“永久邮票”(First-Class Mail Forever stamp)的价格上调约5%,从78美分涨至82美分。该机构还计划将国内明信片的邮寄价格上调6.6%,从61美分涨至65美分。国际明信片的邮寄费用将上涨2.9%,从1.70美元涨至1.75美元。此次拟议的提价须经邮政管理委员会(Postal Regulatory Commission)批准。该委员会是一个联邦机构,负责监管美国邮政总局的费率和邮件服务等事宜。美国邮政总局在一份书面声明中表示:“邮政总局正在动用一切可用工具,包括可用的监管定价权,以确保我们能继续履行普遍服务义务,为美国民众服务。”
The average one-year price target for Zebra Technologies (XTRA:ZT1A) has been revised to 280,67 € / share. This is a decrease of 11.29% from the prior estimate of 316,39 € dated November 16, 2025. The price target is an average of many targets provided by anal
The average one-year price target for Zebra Technologies (XTRA:ZT1A) has been revised to 280,67 € / share. This is a decrease of 11.29% from the prior estimate of 316,39 € dated November 16, 2025. The price target is an average of many targets provided by anal